Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Education

Date Submitted: May 3, 2021
Open Peer Review Period: Apr 24, 2021 - Jun 19, 2021
Date Accepted: Jul 28, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Augmented Reality in Pediatric Septic Shock Simulation: Randomized Controlled Feasibility Trial

Toto RL, Vorel ES, Tay KYE, Good GL, Berdinka JM, Peled A, Leary M, Chang TP, Weiss AK, Balamuth FB

Augmented Reality in Pediatric Septic Shock Simulation: Randomized Controlled Feasibility Trial

JMIR Med Educ 2021;7(4):e29899

DOI: 10.2196/29899

PMID: 34612836

PMCID: 8529461

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Augmented Reality in Pediatric Septic Shock Simulation: A Randomized Controlled Feasibility Trial

  • Regina L Toto; 
  • Ethan S Vorel; 
  • Khoon-Yen E Tay; 
  • Grace L Good; 
  • Jesse M Berdinka; 
  • Adam Peled; 
  • Marion Leary; 
  • Todd P Chang; 
  • Anna K Weiss; 
  • Frances B Balamuth

ABSTRACT

Background:

Septic shock is a low frequency but high stakes condition in children requiring prompt resuscitation, thus making it an important target for simulation based education.

Objective:

In this study, we aimed to 1) design and implement an augmented reality (AR) application (PediSepsisAR) for septic shock simulation; 2) test the feasibility of measuring timing and volume of fluid administration during septic shock simulation with and without PediSepsisAR; 3) describe PediSepsisAR as an educational tool. We hypothesized that we could feasibly measure our desired data during simulation in 90% of participants.

Methods:

We performed a randomized controlled feasibility trial with a convenience sample of pediatric providers at a large tertiary-care pediatric center. Participants completed a pre-study questionnaire and were randomized to either the PediSepsisAR or control (traditional simulation) arms. We measured participants’ rate of administration of 20 cc/kg, 40 cc/kg, and 60 cc/kg IV fluids during a septic shock simulation using each modality. Participants in the PediSepsisAR arm completed a post-study questionnaire. We analyzed data using descriptive statistics and a Wilcoxson Rank Sum test to compare median time to event variables between groups.

Results:

We enrolled 50 participants with 25 in each arm. The timing and volume of fluid administration was captured in 100% of participants. There was no statistically significant difference in time to administration of IV fluids between the two groups. Most participants in the PediSepsisAR group reported that PediSepsisAR enhanced their awareness of the patient’s perfusion.

Conclusions:

We developed an AR application for use in pediatric septic shock simulation and demonstrated the feasibility of measuring volume and timing of fluid administration during simulation using this modality. Our findings suggest AR’s promise as an educational tool, particularly for teaching about shock states.


 Citation

Please cite as:

Toto RL, Vorel ES, Tay KYE, Good GL, Berdinka JM, Peled A, Leary M, Chang TP, Weiss AK, Balamuth FB

Augmented Reality in Pediatric Septic Shock Simulation: Randomized Controlled Feasibility Trial

JMIR Med Educ 2021;7(4):e29899

DOI: 10.2196/29899

PMID: 34612836

PMCID: 8529461

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.